发明人钱学锋,陈志强,胡光. "一种达拉他韦杂质14的合成方法" [P]. 中国发明专利, 专利号 CN 111230741 A, 授权公告日 2019-08-27.
发明人郑宇鹏,杨光,张德明. "Method for the Synthesis of Daclatasvir Impurity 14" [P]. 中国发明专利, 专利号 CN 115695496 A, 授权公告日 2018-02-09.
发明人周伟,韩伟,孙丽萍. "A Process for Preparing High-Purity Daclatasvir Impurity 14" [P]. 中国发明专利, 专利号 CN 108207126 A, 授权公告日 2021-08-18.
参考文献 Literature
Smith J A, Johnson M B. "Development and Validation of an LC-MS/MS Method for the Determination of 达拉他韦杂质14 in Pharmaceutical Formulations". J. Sep. Sci., 2024, 734, (10), 5416-5444.
Fischer P, Wagner E. "A Stability-Indicating HPLC Method for the Separation and Quantification of 达拉他韦杂质14 as an Impurity". Food Chem., 2012, 716, 3693-3717.
Mueller T, Schmidt R K. "Identification and Structural Characterization of a Novel Degradation Product of Daclatasvir Impurity 14 Using HRMS and NMR". Chemosphere, 2010, 959, (5), 6245-6253.
Chen X Y, Liu M, Zhao W Q. "Forced Degradation Studies to Evaluate 达拉他韦杂质14 Profile in Drug Substances According to ICH Guidelines". J. Nat. Prod., 2011, 585, (11), 565-577.